Showing results (761-770 of 1,179) with videos related to

Sort By:
Pageof 118
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 9, 2010
The effects of NOS1 gene on asthma and total IgE levels in Taiwanese children, and the interactions with environmental factorsTsu-Nai Wang, Hsing-I Tseng, Ching-Chu Kao, et al.
Journal of Orthopaedic Surgery and Research|March 2, 2023
Comparison of radiographic and clinical outcomes between ALIF, OLIF, and TLIF over 2-year follow-up: a comparative studyKuan-Kai Tung, Wei-Cheng Tseng, Yun-Che Wu, et al.
Journal of the Chinese Medical Association : JCMA|July 26, 2006
Decrease heart rate variability but preserve postural blood pressure change in type 2 diabetes with microalbuminuriaHarn-Shen Chen, Tzu-En Wu, Tjin-Shing Jap, et al.
Pharmaceutics|November 27, 2021
Telmisartan Loaded Nanofibers Enhance Re-Endothelialization and Inhibit Neointimal HyperplasiaChen-Hung Lee, Kuo-Sheng Liu, Julien George Roth, et al.
Journal of American College Health : J of ACH|July 10, 2019
Effectiveness of a theory of planned behavior-based intervention for promoting periodontal preventive behaviors among medical students in TaiwanHuei-Lan Lee, Ying-Chun Lin, Wu-Der Peng, et al.
Journal of Immunological Methods|October 29, 2003
Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display libraryKerrm Y F Yau, Maria A T Groves, Shenghua Li, et al.
The American Journal of Pathology|April 26, 2011
Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancersChih-Hung Lee, Shi-Bei Wu, Chien-Hui Hong, et al.
Molecular Cancer Therapeutics|March 18, 2011
Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistanceI-Ping Huang, Shu-Pin Sun, Shih-Hsun Cheng, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 2, 2025
Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic DermatitisGilles Tiraboschi, Kim Papp, Thomas Bieber, et al.
Pageof 118